Polar Capital Global Healthcare Trst : Top Ten Equity Holdings and Exposures

14^th January 2019

Polar Capital Global Healthcare Trust plc (the 'Company')

Top Ten Equity Holdings and Sector and Geographic Exposure as at 31^st December 2018 and full Portfolio listing as at 30^th November 2018 available from company's website

Polar Capital Global Healthcare Trust plc is pleased to announce that as at 31^st December 2018 the top ten equity holdings and the sector and geographic breakdown were as follows:

Top 10 Holdings	%
Johnson & Johnson	8.3%
Medtronic	6.3%
UnitedHealth Group	5.9%
Merck & Co	5.7%
Novartis	5.6%
Amgen	4.8%
Novo Nordisk A/S	4.8%
Abbott Laboratories	4.5%
CVS Health Corp	4.4%
Takeda Pharmaceutical	4.0%
Total	54.4%

Sector Exposure	%
Pharmaceuticals	35.6%
Healthcare Equipment	28.6%
Biotechnology	18.3%
Managed Healthcare	9.0%
Life Sciences Tools & Services	6.2%
Drug Retail	4.4%
Healthcare Facilities	4.0%
Healthcare Services	3.0%
Healthcare Supplies	1.7%
Healthcare Technology	0.7%
Education Services	0.4%
Cash	-12.0%
Total	100.0%

Geographic Exposure	%
United States	70.8%
United Kingdom	10.8%
Ireland	9.0%
Japan	6.0%
Switzerland	5.6%
Denmark	4.7%
Spain	3.2%
Sweden	0.9%
Italy	0.5%
Norway	0.4%
Cash	-12.0%
Total	100.0%

Gearing Ratio as calculated in accordance with the guidelines of the Association of Investment Companies, was 12.22%. Gearing is made up of structural debt provided by the subsidiary company PCGH ZDP plc, through the issue of zero dividend preference shares.

The monthly factsheet will usually be available on the Company's website on the 10^th working day after the month end and includes a commentary by the investment manager. www.Polarcapitalhealthcaretrust.co.uk

Neither the contents of the Company's website nor the contents of any website accessible from the hyperlinks on the Company's website (or any other website) is incorporated into or forms part of this announcement.